GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lasa Supergenerics Ltd (BOM:540702) » Definitions » Deferred Tax

Lasa Supergenerics (BOM:540702) Deferred Tax : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lasa Supergenerics Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Lasa Supergenerics's change in deferred tax for the three months ended in Dec. 2024 was ₹0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Lasa Supergenerics Deferred Tax Historical Data

The historical data trend for Lasa Supergenerics's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lasa Supergenerics Deferred Tax Chart

Lasa Supergenerics Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only - - - - -

Lasa Supergenerics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lasa Supergenerics Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lasa Supergenerics Deferred Tax Related Terms

Thank you for viewing the detailed overview of Lasa Supergenerics's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Lasa Supergenerics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lasa Supergenerics Ltd (BOM:540702) » Definitions » Deferred Tax
Comparable Companies
BOM:537253 BOM:524652 BOM:524396 BOM:530317 BOM:506919 BOM:524711 BOM:539561 NSE:JFLLIFE BOM:538964 BOM:506128 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
LASA:India
Address
Plot No C-4, C-4/1, MIDC, Lote Parshuram Industrial Area, Khed Taluka, Ratnagiri, MH, IND, 415722
Website
https://lasalabs.com
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, Pharmaceuticals, drugs, and others. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products.

Lasa Supergenerics Headlines

No Headlines